The Sigfried and Janet Weis Center for Research, Geisinger Clinic, 100 North Academy Avenue, Pennsylvania 17822-2610, USA.
BMC Med Genomics. 2012 Jun 15;5:25. doi: 10.1186/1755-8794-5-25.
Abdominal aortic aneurysm (AAA) is a dilatation of the aorta affecting most frequently elderly men. Histologically AAAs are characterized by inflammation, vascular smooth muscle cell apoptosis, and extracellular matrix degradation. The mechanisms of AAA formation, progression, and rupture are currently poorly understood. A previous mRNA expression study revealed a large number of differentially expressed genes between AAA and non-aneurysmal control aortas. MicroRNAs (miRNAs), small non-coding RNAs that are post-transcriptional regulators of gene expression, could provide a mechanism for the differential expression of genes in AAA.
To determine differences in miRNA levels between AAA (n = 5) and control (n = 5) infrarenal aortic tissues, a microarray study was carried out. Results were adjusted using Benjamini-Hochberg correction (adjusted p < 0.05). Real-time quantitative RT-PCR (qRT-PCR) assays with an independent set of 36 AAA and seven control tissues were used for validation. Potential gene targets were retrieved from miRNA target prediction databases Pictar, TargetScan, and MiRTarget2. Networks from the target gene set were generated and examined using the network analysis programs, CytoScape® and Ingenuity Pathway Core Analysis®.
A microarray study identified eight miRNAs with significantly different expression levels between AAA and controls (adjusted p < 0.05). Real-time qRT-PCR assays validated the findings for five of the eight miRNAs. A total of 222 predicted miRNA target genes known to be differentially expressed in AAA based on a prior mRNA microarray study were identified. Bioinformatic analyses revealed that several target genes are involved in apoptosis and activation of T cells.
Our genome-wide approach revealed several differentially expressed miRNAs in human AAA tissue suggesting that miRNAs play a role in AAA pathogenesis.
腹主动脉瘤(AAA)是一种主动脉扩张疾病,最常影响老年男性。组织学上,AAA 的特征是炎症、血管平滑肌细胞凋亡和细胞外基质降解。AAA 的形成、进展和破裂的机制目前知之甚少。先前的 mRNA 表达研究表明,AAA 和非动脉瘤性对照主动脉之间存在大量差异表达的基因。微小 RNA(miRNA)是一种小的非编码 RNA,是基因表达的转录后调节因子,可能为 AAA 中基因的差异表达提供了一种机制。
为了确定 AAA(n=5)和对照(n=5)下腔主动脉组织之间 miRNA 水平的差异,进行了微阵列研究。结果使用 Benjamini-Hochberg 校正(调整后的 p<0.05)进行调整。使用独立的 36 个 AAA 和 7 个对照组织的实时定量 RT-PCR(qRT-PCR)检测进行验证。从 miRNA 靶标预测数据库 Pictar、TargetScan 和 MiRTarget2 中检索潜在的基因靶标。使用网络分析程序 CytoScape®和 Ingenuity Pathway Core Analysis®生成和检查靶基因集的网络。
微阵列研究确定了 8 种 miRNA 在 AAA 和对照组之间的表达水平有显著差异(调整后的 p<0.05)。实时 qRT-PCR 检测验证了这 8 种 miRNA 中的 5 种。总共鉴定出 222 个已知在 AAA 中基于先前的 mRNA 微阵列研究差异表达的预测 miRNA 靶基因。生物信息学分析表明,一些靶基因参与细胞凋亡和 T 细胞激活。
我们的全基因组方法揭示了人类 AAA 组织中几种差异表达的 miRNA,表明 miRNA 在 AAA 的发病机制中发挥作用。